Vol. 1 No. 3 (2024): SMART-MD Journal of Precision Medicine (Fall 2024)

Fall 2024 Issue Spotlight: Pancreatic Cancer

This edition emphasizes the Early Diagnosis of Pancreatic Cancer, featuring articles on differentiating Autoimmune Pancreatitis (AIP) from other conditions with similar early signs and symptoms, and pinpointing PDAC High-Risk Individuals (HRI-C) through a blend of genetic risk factors and new biomarkers for early signs of Pancreatic Ductal Adenocarcinoma (PDAC).

For treatment, the focus is on chemotherapy regimens like FOLFIRINOX, with discussions on the high chemotoxicity linked to genetic variations in drug metabolism, particularly for irinotecan and 5-FU. Two standout papers delve into pharmacogenetics.

Bookmark this issue and share it with your network! Let's make precision medicine the forefront of pancreatic cancer detection and treatment from the outset.